Pfizer has consented to pay USD 43 billion for biotech Seagen and its spearheading class of designated disease sedates, The Money Road Diary reported. Under the terms, Pfizer would pay
Business
Mar 14, 2023
Mar 13, 2026
Mar 10, 2026
Mar 9, 2026
